Clik here to view.
HemaCare与Charles River Laboratories合作向中国提供人源生物材料
洛杉矶 (美国商业资讯)–HemaCare Corporation (OTCMKTS: HEMA)是面向生物医药研究、药物发现和细胞疗法工艺开发的人源生物制品和服务定制的全球领先者和可信赖品牌，该公司今天宣布，与Charles River的子公司Vital River签署分销协议，向中国科学界提供直接获取健康和疾病状态人类原始细胞的途径。 北京维通利华饰演动物技术有限公司（Beijing...
View ArticleClik here to view.
DxPx partners with MyBioGate for China
DUESSELDORF, Germany DxPx Conference has another strong partner: MyBioGate Inc.. “Our cooperation with MyBioGate gives us access to the Chinese markets and further increases our Conference’s impetus...
View ArticleClik here to view.
Kyowa Kirin Announces FDA Approval of NOURIANZ™ (istradefylline) for Use in...
TOKYO Kyowa Kirin Co., Ltd., (Kyowa Kirin, TYO: 4151) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for NOURIANZ™ (istradefylline) for use as adjunctive...
View ArticleClik here to view.
Phillips-Medisize Highlights Innovations in Drug Delivery and Digital Health...
HUDSON, Wis. Phillips-Medisize, a Molex company, announces a significant exhibiting and speaking presence at the Suzhou Dialogue conference, organized by the China National Pharmaceutical Packaging...
View ArticleClik here to view.
EdiGENE Changes Name to Modalis Therapeutics
TOKYO & CAMBRIDGE, Mass. EdiGENE Corporation today announced that the company has changed its name to Modalis Therapeutics Corporation. Modalis (pronounced “MO-DA-LIS”) is an original name that...
View ArticleClik here to view.
Invicro Names Mr. Hidenori Seshimo as Vice President of Biomarker Services,...
BOSTON Invicro LLC, a Konica Minolta company and a leading provider of imaging biomarkers, core lab services and software for research and drug development, today announced the appointment of Mr....
View ArticleClik here to view.
Clik here to view.
PCI在爱尔兰进行投资以巩固在欧洲的地位
费城 (美国商业资讯)–领先的生物制药外包服务提供商PCI(Pharma Services PCI)通过战略投资深化在爱尔兰的布局和扩大在欧洲的布点，来巩固其在欧盟的领先地位。...
View ArticleClik here to view.
インヴィクロが瀬下秀則を日本におけるバイオマーカーサービス担当バイスプレジデントとして任命
ボストン （ビジネスワイヤ） — コニカミノルタの子会社で、研究・医薬品開発向けのイメージングバイオマーカー、コアラボサービス、ソフトウエアを提供する一流企業のインヴィクロは本日、日本におけるバイオマーカーサービス担当バイスプレジデントとして瀬下秀則（工学修士）を任命したと発表しました。...
View ArticleClik here to view.
Uni-Bio Science Group Limited: 2019 Interim Results
HONG KONG A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (the “Company”, together with its subsidiaries, the “Group”; Stock code: 0690.HK) are pleased to announce that...
View ArticleClik here to view.
Genentech Presents Positive Phase III Study Results for One-dose Xofluza...
SOUTH SAN FRANCISCO, Calif. Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III MINISTONE-2 study showed that one-dose Xofluza™ (baloxavir...
View ArticleClik here to view.
Positive Phase III Results Show Xofluza (Baloxavir Marboxil) Reduces Risk of...
SOUTH SAN FRANCISCO, Calif. Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III BLOCKSTONE study showed preventive treatment with Xofluza™...
View ArticleClik here to view.
ITM and DCB Sign Exclusive Licensing & Development Agreement for Solucin® TRT...
MUNICH & GARCHING, Germany ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and DuChemBio Co, Ltd. (DCB), a leading Korean...
View ArticleClik here to view.
Insilico Medicine Develops and Validates Powerful AI System To Transform Drug...
HONG KONG Insilico Medicine has developed GENTRL, a new artificial intelligence system for drug discovery that dramatically accelerates the process from years to days. In the industry’s first...
View ArticleClik here to view.
PCIがアイルランドでの投資により欧州における地位強化
フィラデルフィア （ビジネスワイヤ） — バイオ製薬アウトソーシング・サービスを提供する一流企業のPCIファーマ・サービシズ（PCI）は、アイルランドにおけるプレゼンスを強化し、欧州での足場を拡大するための戦略的投資により、EUにおけるリーダーの地位を強固なものにしました。...
View ArticleClik here to view.
Genor Biopharma, a Pre-commercial Stage Biopharma Company, Announced the...
SHANGHAI Before joining Genor, Dr. Hu served as Managing Director and Head of APAC Healthcare Research at Deutsche Bank, where he covered Asia/China healthcare. Dr. Hu joined Deutsche Bank in 2010...
View ArticleClik here to view.
Invicro任命Hidenori Seshimo先生为日本生物标记物服务副总裁
波士顿 (美国商业资讯)–Invicro LLC隶属于柯尼卡美能达公司(Konica Minolta)，是一家领先的影像学生物标记物、核心实验室服务和研究及药物开发软件提供商。该公司今天宣布，任命工程学硕士Hidenori Seshimo先生为日本生物标记物服务副总裁。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Shinkowa Pharmaceutical: Presale Orders for the New NMN PURE 900
TOKYO Shinkowa Pharmaceutical Co., Ltd. (Head office: Chuo Ward, Tokyo, Japan, CEO: Megumi Tanaka) commercialized the world’s first nutraceuticals and cosmetics containing β-nicotinamide...
View ArticleClik here to view.
Astex Pharmaceuticals Announces That Its Novel, Oral Hypomethylating Agent...
PLEASANTON, Calif. Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Tokyo, Japan, announces that the US Food & Drug Administration (FDA) has...
View ArticleClik here to view.
Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage...
INGELHEIM, Germany & MUMBAI, India Boehringer Ingelheim and Lupin Limited (Lupin) today announced a licensing, development and commercialization agreement for Lupin’s MEK inhibitor compound...
View Article